Efficacy of Novel SPAK Inhibitor ZT-1a Derivatives (1c, 1d, 1g & 1h) on Improving Post-stroke Neurological Outcome and Brain Lesion in Mice
Overview
Authors
Affiliations
SPAK inhibitor ZT-1a was previously shown to be neuroprotective in murine ischemic stroke models. In this study, we further examined the efficacy of four ZT-1a derivatives (ZT-1c, -1d, -1g and -1h) on reducing stroke-induced sensorimotor function impairment and brain lesions. Vehicle control (Veh) or ZT-1 derivatives were administered via osmotic pump to adult C57BL/6J mice during 3-21 h post-stroke. Neurological behavior of these mice was assessed at days 1, 3, 5, and 7 post-stroke and MRI T2WI and DTI analysis was subsequently conducted in ex vivo brains. Veh-treated stroke mice displayed sensorimotor function deficits compared to Sham mice. In contrast, mice receiving ZT-1a derivatives displayed significantly lower neurological deficits at days 3-7 post-stroke (p < 0.05), with ZT-1a, ZT-1c and ZT-1d showing greater impact than ZT-1h and ZT-1g. ZT-1a treatment was the most effective in reducing brain lesion volume on T2WI and in preserving NeuN + neurons (p < 0.01), followed by ZT-1d > -1c > -1g > -1h. The Veh-treated stroke mice displayed white matter tissue injury, reflected by reduced fractional anisotropy (FA) or axial diffusivity (AD) values in external capsule, internal capsule and hippocampus. In contrast, only ZT-1a-as well as ZT-1c-treated stroke mice exhibited significantly higher FA and AD values. These findings demonstrate that post-stroke administration of SPAK inhibitor ZT-1a and its derivatives (ZT-1c and ZT-1d) is effective in protecting gray and white matter tissues in ischemic brains, showing a potential for ischemic stroke therapy development.
Ion transporter cascade, reactive astrogliosis and cerebrovascular diseases.
Rahman M, Islam R, Bhuiyan M Front Pharmacol. 2024; 15:1374408.
PMID: 38659577 PMC: 11041382. DOI: 10.3389/fphar.2024.1374408.
Liu R, Berry R, Wang L, Chaudhari K, Winters A, Sun Y Transl Stroke Res. 2024; .
PMID: 38488999 DOI: 10.1007/s12975-024-01241-0.
Lam P, Newland J, Faull R, Kwakowsky A Molecules. 2023; 28(3).
PMID: 36771011 PMC: 9920462. DOI: 10.3390/molecules28031344.